Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO GI 2021 | Novel approaches in the treatment of GI malignancies

Joshua E. Meyer • 20 Jan 2021
ASCO GI 2021
Gastrointestinal Cancer Rectal Cancer

Joshua E. Meyer, MD, Fox Chase Cancer Center, Philadelphia, PA, discusses upcoming advances in rectal cancer and highlights the importance of a personalized approach to treating this patient population. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Joshua E. Meyer

3:05
Alliance A021501: preoperative mFOLFIRINOX +/- hypofractionated RT for pancreatic cancer
Joshua E. Meyer • 20 Jan 2021
2:25
Adjuvant therapy for esophageal cancer
Joshua E. Meyer • 20 Jan 2021

Related Videos

1:53
Important pathophysiological determinants of elevated cirDNA post-surgery
Alain Thierry • 9 Apr 2024
0:47
Emerging molecular drivers and biomarker targets in gastroesophageal cancers
Tatsuhiro Shibata • 9 Apr 2024
0:52
DRP-104 with durvalumab in fibrolamellar hepatocellular carcinoma
Marina Baretti • 9 Apr 2024
1:06
The emerging role of cancer vaccines in treating liver cancer
Marina Baretti • 9 Apr 2024
The content of VJOncology is intended for healthcare professionals